Alexandre Gibim was appointed Head of North America for Advanced Accelerator Applications (AAA), a Novartis company, in January 2022. He is also a member of the Novartis US Oncology Leadership Team. Prior to his appointment, Alexandre, also known as Gibim, served as the Novartis Oncology General Manager for the Greater China region since 2019. During his tenure, he led multiple, highly-successful business and portfolio transformations, achieving high double digit growth rates and doubling the workforce to 1,200 associates. Gibim also instituted a cultural transformation that led to a dramatic improvement in organizational engagement across all business functions. From 2015 to 2018, Gibim was the Country President for Novartis Brazil and General Manager of Oncology. He first joined Novartis in 2011, as the General Manager for Vaccines & Diagnostics of Novartis Brazil, holding roles of increasing responsibility over his tenure. Among his successes was the integration of a new biotech manufacturing plant. From 2010 to 2011, Gibim served as Brazil Country President and Oncology General Manager for Astellas Pharma, establishing a new market and organization for the company. Prior to this, he worked at Eli Lilly from 1994 to 2009, advancing positions across various functions including Finance, Business Development, Sales and Marketing, with additional experience in the Specialty Business and Primary Care/Pharma divisions. Gibim has developed strong multi-cultural awareness, having worked in various countries during this career, including the US, China and Brazil, and led multiple projects in Canada, Australia, Japan, Taiwan, Russia, India, Korea and Latin America. His accomplishments include performance turnarounds, culture transformations, technology transfers deals, innovative go-to-market strategies, acquisitions, and divestments. Alexandre Gibim received his Certificate in Sales & Marketing from Northwestern University – Kellogg School of Management, and a Bachelor’s degree in Business Management.